Psilocybin Shows Rapid Depression Relief, but Long-Term Gains Fade
A single dose of psilocybin rapidly reduced depression symptoms in a small Swedish trial, but the advantage over a placebo faded within a year.
Key points
- A 25-mg dose of psilocybin reduced depression symptoms within two days, with effects lasting over three months.
- The advantage over a niacin placebo disappeared by the one-year mark on clinician-rated measures.
- Blinding failed, as 94% of psilocybin recipients correctly identified their treatment.
- The study involved only 35 participants, limiting the generalizability of the findings.
Background
Previous research has explored psilocybin as a rapid-acting treatment for depression, but long-term benefits have been difficult to confirm due to methodological limitations. This trial adds to the body of evidence on the drug's potential as an alternative to traditional antidepressants.
Why it matters
The findings suggest that while psilocybin can provide quick relief, its long-term efficacy may not surpass that of standard treatments or natural remission, highlighting the need for further research into repeated dosing or adjunctive strategies.
What to watch
Researchers will likely investigate repeated dosing or combined treatment approaches to sustain the antidepressant effects of psilocybin beyond the initial months.
Want the full story? Read the original reporting
Read on PsyPost